These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26586786)

  • 1. EMBRACE STEMI study: a Phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention.
    Gibson CM; Giugliano RP; Kloner RA; Bode C; Tendera M; Jánosi A; Merkely B; Godlewski J; Halaby R; Korjian S; Daaboul Y; Chakrabarti AK; Spielman K; Neal BJ; Weaver WD
    Eur Heart J; 2016 Apr; 37(16):1296-303. PubMed ID: 26586786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale and design of the EMBRACE STEMI study: a phase 2a, randomized, double-blind, placebo-controlled trial to evaluate the safety, tolerability and efficacy of intravenous Bendavia on reperfusion injury in patients treated with standard therapy including primary percutaneous coronary intervention and stenting for ST-segment elevation myocardial infarction.
    Chakrabarti AK; Feeney K; Abueg C; Brown DA; Czyz E; Tendera M; Janosi A; Giugliano RP; Kloner RA; Weaver WD; Bode C; Godlewski J; Merkely B; Gibson CM
    Am Heart J; 2013 Apr; 165(4):509-514.e7. PubMed ID: 23537966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of Left Ventricular Mass and Infarct Size in Anterior Wall ST-Segment Elevation Acute Myocardial Infarction (from the EMBRACE STEMI Clinical Trial).
    Daaboul Y; Korjian S; Weaver WD; Kloner RA; Giugliano RP; Carr J; Neal BJ; Chi G; Cochet M; Goodell L; Michalak N; Rusowicz-Orazem L; Alkathery T; Allaham H; Routray S; Szlosek D; Jain P; Gibson CM
    Am J Cardiol; 2016 Sep; 118(5):625-31. PubMed ID: 27392509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of delta-protein kinase C by delcasertib as an adjunct to primary percutaneous coronary intervention for acute anterior ST-segment elevation myocardial infarction: results of the PROTECTION AMI Randomized Controlled Trial.
    Lincoff AM; Roe M; Aylward P; Galla J; Rynkiewicz A; Guetta V; Zelizko M; Kleiman N; White H; McErlean E; Erlinge D; Laine M; Dos Santos Ferreira JM; Goodman S; Mehta S; Atar D; Suryapranata H; Jensen SE; Forster T; Fernandez-Ortiz A; Schoors D; Radke P; Belli G; Brennan D; Bell G; Krucoff M;
    Eur Heart J; 2014 Oct; 35(37):2516-23. PubMed ID: 24796339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results.
    Atar D; Arheden H; Berdeaux A; Bonnet JL; Carlsson M; Clemmensen P; Cuvier V; Danchin N; Dubois-Randé JL; Engblom H; Erlinge D; Firat H; Halvorsen S; Hansen HS; Hauke W; Heiberg E; Koul S; Larsen AI; Le Corvoisier P; Nordrehaug JE; Paganelli F; Pruss RM; Rousseau H; Schaller S; Sonou G; Tuseth V; Veys J; Vicaut E; Jensen SE
    Eur Heart J; 2015 Jan; 36(2):112-9. PubMed ID: 25179768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Shenfu Injection on Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial.
    Wang X; Miao H; Yan Y; Guo R; Gong W; He Y; Wang H; Ma X; Nie S
    Front Cardiovasc Med; 2021; 8():736526. PubMed ID: 34926601
    [No Abstract]   [Full Text] [Related]  

  • 9. A Randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI.
    Adlam D; Zarebinski M; Uren NG; Ptaszynski P; Oldroyd KG; Munir S; Zaman A; Contractor H; Kiss RG; Édes I; Szachniewicz J; Nagy GG; Garcia MJ; Tomcsanyi J; Irving J; Sharp ASP; Musialek P; Lupkovics G; Shirodaria C; Selvanayagam JB; Quinn P; Ng L; Roth M; Insko MA; Haber B; Hill S; Siegel L; Tulloch S; Channon KM
    Int J Cardiol; 2022 Jan; 347():1-7. PubMed ID: 34774885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
    Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
    J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rationale and design of the 'MITOCARE' Study: a phase II, multicenter, randomized, double-blind, placebo-controlled study to assess the safety and efficacy of TRO40303 for the reduction of reperfusion injury in patients undergoing percutaneous coronary intervention for acute myocardial infarction.
    MITOCARE Study Group
    Cardiology; 2012; 123(4):201-7. PubMed ID: 23202613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trial design and rationale of TY-51924 as a novel Na+/H+ exchanger inhibitor in patients with ST-elevation acute myocardial infarction undergoing percutaneous coronary intervention.
    Ishihara M; Asakura M; Kimura K; Nakao K; Hamada C; Hirayama A
    J Cardiol; 2014 Jan; 63(1):82-7. PubMed ID: 23860273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
    Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rationale and design of a double-blind, multicenter, randomized, placebo-controlled clinical trial of early administration of intravenous β-blockers in patients with ST-elevation myocardial infarction before primary percutaneous coronary intervention: EARLY β-blocker administration before primary PCI in patients with ST-elevation myocardial infarction trial.
    Roolvink V; Rasoul S; Ottervanger JP; Dambrink JH; Lipsic E; van der Horst IC; de Smet B; Kedhi E; Marcel Gosselink AT; Piek JJ; Sanchez-Brunete V; Ibanez B; Fuster V; Van't Hof AW;
    Am Heart J; 2014 Nov; 168(5):661-6. PubMed ID: 25440793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
    Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
    J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
    Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
    Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of peak creatine kinase-MB measurements in predicting myocardial infarct size, left ventricular dysfunction, and outcome after first anterior wall acute myocardial infarction (from the INFUSE-AMI trial).
    Dohi T; Maehara A; Brener SJ; Généreux P; Gershlick AH; Mehran R; Gibson CM; Mintz GS; Stone GW
    Am J Cardiol; 2015 Mar; 115(5):563-70. PubMed ID: 25586335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating HtrA2 as a novel biomarker for mitochondrial induced cardiomyocyte apoptosis and ischemia-reperfusion injury in ST-segment elevation myocardial infarction.
    Hortmann M; Robinson S; Mohr M; Haenel D; Mauler M; Stallmann D; Reinoehl J; Duerschmied D; Peter K; Bode C; Ahrens I
    Int J Cardiol; 2017 Sep; 243():485-491. PubMed ID: 28602551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Postconditioning reduces enzymatic infarct size and improves microvascular reperfusion in patients with ST-segment elevation myocardial infarction.
    Araszkiewicz A; Grygier M; Pyda M; Rajewska J; Michalak M; Lesiak M; Grajek S
    Cardiology; 2014; 129(4):250-7. PubMed ID: 25402666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Early Treatment With Melatonin to Reduce Infarct Size in Patients With ST-Segment Elevation Myocardial Infarction Receiving Percutaneous Coronary Intervention (From the Melatonin Adjunct in the Acute Myocardial Infarction Treated With Angioplasty Trial).
    Dominguez-Rodriguez A; Abreu-Gonzalez P; de la Torre-Hernandez JM; Consuegra-Sanchez L; Piccolo R; Gonzalez-Gonzalez J; Garcia-Camarero T; Del Mar Garcia-Saiz M; Aldea-Perona A; Reiter RJ;
    Am J Cardiol; 2017 Aug; 120(4):522-526. PubMed ID: 28645475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.